EUVIMEDScopri EUVIMED
Übersichtsarbeit

Explainability and white box in drug discovery

Kevser Kübra Kırboğa iD, Sumra Abbasi, Ecir Uğur Küçüksille

Chemical Biology & Drug Design · 2023-07 · 102 (1) · 217-233

DOI: 10.1111/cbdd.14262 ↗

At a glance

Übersichtsarbeit in Chemical Biology & Drug Design, published online on 2023-04-27. Written by Kevser Kübra Kırboğa and 2 co-authors. Institution: Bioengineering Department, Bilecik Seyh Edebali University, Bilecik, Turkey. Major MEDLINE topics: Artificial Intelligence, Algorithms. Cited 60 times so far (Crossref); 144 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Recently, artificial intelligence (AI) techniques have been increasingly used to overcome the challenges in drug discovery. Although traditional AI techniques generally have high accuracy rates, there may be difficulties in explaining the decision process and patterns. This can create difficulties in understanding and making sense of the outputs of algorithms used in drug discovery. Therefore, using explainable AI (XAI) techniques, the causes and consequences of the decision process are better understood. This can help further improve the drug discovery process and make the right decisions. To address this issue, Explainable Artificial Intelligence (XAI) emerged as a process and method that securely captures the results and outputs of machine learning (ML) and deep learning (DL) algorithms. Using techniques such as SHAP (SHApley Additive ExPlanations) and LIME (Locally Interpretable Model‐Independent Explanations) has made the drug targeting phase clearer and more understandable. XAI methods are expected to reduce time and cost in future computational drug discovery studies. This review provides a comprehensive overview of XAI‐based drug discovery and development prediction. XAI mechanisms to increase confidence in AI and modeling methods. The limitations and future directions of XAI in drug discovery are also discussed.

Subjects

MeSH terms (MEDLINE)

Artificial IntelligenceAlgorithmsDrug Delivery SystemsDrug DiscoveryMachine Learning

Author keywords

artificial intelligencecomputational drug discoverydrug developmentexplainable artificial intelligence

Authors and institutions

  • Bioengineering Department, Bilecik Seyh Edebali University, Bilecik, Turkey.
  • Informatics Institute, Istanbul Technical University, Maslak, Turkey.
  • Department of Biological Sciences, National of Medical Sciences, Rawalpindi, Pakistan.
  • Department of Computer Engineering, Süleyman Demirel University, Isparta, Turkey.

ORCID profiles: Kevser Kübra Kırboğa

Cite

APA

Kırboğa, K. K., Abbasi, S., & Küçüksille, E. U. (2023). Explainability and white box in drug discovery. Chemical Biology & Drug Design, 102(1), 217-233. https://doi.org/10.1111/cbdd.14262

Vancouver

Kırboğa KK, Abbasi S, Küçüksille EU. Explainability and white box in drug discovery. Chemical Biology & Drug Design. 2023;102(1):217-233. doi:10.1111/cbdd.14262

BibTeX
@article{Krboa2023,
  author = {Kırboğa, Kevser Kübra and Abbasi, Sumra and Küçüksille, Ecir Uğur},
  title = {Explainability and white box in drug discovery},
  journal = {Chemical Biology & Drug Design},
  year = {2023},
  volume = {102},
  number = {1},
  pages = {217--233},
  doi = {10.1111/cbdd.14262}
}
Start for free →